<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01524744</url>
  </required_header>
  <id_info>
    <org_study_id>87909</org_study_id>
    <secondary_id>87909</secondary_id>
    <nct_id>NCT01524744</nct_id>
  </id_info>
  <brief_title>A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mashhad University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mashhad University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of topical Pimecrolimus with adcortyl on
      erosive-atrophic 0ral lichen planus in a randomized clinical trial study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>signs of oral lichen planus</measure>
    <time_frame>every 2 weeks</time_frame>
    <description>size and type of oral lichen planus has been recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>symptoms of oral lichen planus</measure>
    <time_frame>every 2 weeks</time_frame>
    <description>pain of oral lesions has been recorded</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Oral Lichen Planus</condition>
  <arm_group>
    <arm_group_label>Pimecrolimus ointment 0.1 %</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group used drugs 3 times a day for 2 months and then didn't eat or drink for 20 minutes after use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adcortyle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group used adcortyle (triamcinolone acetonide 0.1% in orabase, Bristol-Myers Squibbb, Anagn, Italy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pimecrolimus ointment</intervention_name>
    <description>Case group used drugs 3 times a day for 2 months and then didn't eat or drink for 20 minutes after use</description>
    <arm_group_label>Pimecrolimus ointment 0.1 %</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adcortyl</intervention_name>
    <description>triamcinolone acetonide 0.1% in orabase</description>
    <arm_group_label>Pimecrolimus ointment 0.1 %</arm_group_label>
    <arm_group_label>Adcortyle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy confirmed oral lichen planus in combination with a compatible clinical
             appearance was used for diagnosis.

        Exclusion Criteria:

          -  Unable to undergo oral biopsy for diagnosis

          -  Systemic diseases or malignancy

          -  Pregnancy

          -  Lesion/lesions with dysplasia/ history of allergic reaction to corticosteroids or
             immunomodulatory drugs.

          -  Lesions adjacent to amalgam filling were also excluded from this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>atessa pakfetrat, associate professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mashhad University of Medical Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mashhad University of Medical Science</name>
      <address>
        <city>Mashhad</city>
        <state>Khorasan Razavi</state>
        <zip>91735</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2012</study_first_submitted>
  <study_first_submitted_qc>February 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2012</study_first_posted>
  <last_update_submitted>February 1, 2012</last_update_submitted>
  <last_update_submitted_qc>February 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mashhad University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>ATESSA PAKFETRAT</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>oral lichen planus treatment pimecrolimus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lichen Planus</mesh_term>
    <mesh_term>Lichen Planus, Oral</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pimecrolimus</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Tacrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

